Uremic cardiac autonomic neuropathy: Clinical evaluation with heart rate variability and metaiodobenzylguanidine

Handbook of the Autonomic Nervous System in Health and Disease

Volumn , Issue , 2002, Pages 403-423

  Kurata, Chinori ^a  

^a Yamaha Health Care Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35348982112     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Kersh ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974; 290:650-653.
2. Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975; 15:424-429.
3. Röckel A, Hennemann H, Sternagel-Haase A, Heidland A. Uraemic sympathetic neuropathy after haemodialysis and transplantation. Eur J Clin Invest 1979; 9:23-27.
4. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981; 20:246-253.
5. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
6. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321-1328.
7. Takahashi H, Matsuo S, Toriyama T, Kawahara H, Hayano J. Autonomic dysfunction in hemodialysis patients with persistent hypotension. Nephron 1996; 72:418-423.
8. Pelosi G, Emdin M, Carpeggiani C, Morales MA, Piacenti M, Dattolo P, Cerrai T, Macerata A, L’Abbate A, Maggiore Q. Impaired sympathetic response before intra-dialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Clin Sci (Colch) 1999; 96:23-31.
9. Nishiyama K, Kurata C, Wakabayashi Y, Ohno R. Disorders accompanied with marked abnormality of cardiac autonomic function: 24-hour heart rate variability (abstr). J Jpn Soc Intern Med 1996; 85:99.
10. Vita G, Dattola R, Calabro R, Manna L, Venuto C, Toscano A, Savica V, Bellinghieri G. Comparative analysis of autonomic and somatic dysfunction in chronic uraemia. Eur Neurol 1988; 28:335-340.
11. Molgaard H, Christensen PD, Sorensen KE, Christensen CK, Mogensen CE. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992; 41:812-817.
12. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998; 98:961-968.
13. Burger AJ, Weinrauch LA, D’Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999; 84:687-691.
14. Vita G, Bellinghieri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999; 56:232-237.
15. Tamura K, Tsuji H, Nishiue T, Yajima I, Higashi T, Iwasaka T. Determinants of heart rate variability in chronic hemodialysis patients. Am J Kidney Dis 1998; 31:602-606.
16. Steinberg AA, Mars RL, Goldman DS, Percy RF. Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol 1998; 82:1156-1158.
17. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 1999; 10:1972-1981.
18. Mallamaci F, Zoccali C, Ciccarelli M, Briggs JD. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol 1986; 25:175-180.
19. Malik S, Winney RJ, Ewing DJ. Chronic renal failure and cardiovascular autonomic function. Nephron 1986; 43:191-195.
20. Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B. Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 2000; 248:21-26.
21. Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, Hishida A, Ishikawa K, Tawarahara K, Shouda S, Mikami T. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 2000; 84:312-319.
22. Corder CN, Sharma J, McDonald RH Jr. Variable levels of plasma catecholamines and dopamine beta-hydroxylase in hemodialysis patients. Nephron 1980; 25:267-272.
23. Musso NR, Deferrari G, Pende A, Vergassola C, Saffioti S, Gurreri G, Lotti G. Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. Nephron 1989; 51:344-349.
24. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93:1043-1065.
25. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84:482-492.
26. Forsström J, Forsström J, Heinonen E, Välimäki I, Antila K. Effects of haemodial-ysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest 1986; 46:665-670.
27. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 1987; 45:202-206.
28. Thomson BJ, McAreavey D, Neilson JM, Winney RJ, Ewing DJ. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clin Auton Res 1991; 1:131-133.
29. Cloarec-Blanchard L, Girard A, Houhou S, Grünfeld JP, Elghozi JL. Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int 1992; 37(suppl):S14-18.
30. Enzmann G, Bianco F, Paolini F, Panzetta G. Autonomic nervous function and blood volume monitoring during hemodialysis. Int J Artif Organs 1995; 18:504-508.
31. 123I-labeled metaiodobenzylguani-dine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 1996; 3:508-515.
32. Kirvela M, Salmela K, Toivonen L, Koivusalo AM, Lindgren L. Heart rate variability in diabetic and non-diabetic renal transplant patients. Acta Anaesthesiol Scand 1996; 40:804-808.
33. Yildiz A, Akkaya V, Sever MS, Bozfakioglu S, Kudat H, Demirel S, Ark E. Heart rate variability in patients with secondary amyloidosis. Isr J Med Sci 1997; 33:781-785.
34. Kirvela M, Toivonen L, Lindgren L. Cardiac repolarization interval in end-stage diabetic and nondiabetic renal disease. Clin Cardiol 1997; 20:791-796.
35. Tamura K, Tsuji H, Nishiue T, Tokunaga S, Yajima I, Higashi T, Iwasaka T. Determinants of ventricular arrhythmias in hemodialysis patients. Evaluation of the effect of arrhythmogenic substrate and autonomic imbalance. Am J Nephrol 1998; 18:280-284.
36. Deligiannis A, Kouidi E, Tourkantonis A. Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol 1999; 84:197-202.
37. Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q. Parasympathetic function in haemodialysis patients. Nephron 1986; 44:351-354.
38. Roger SD, Baker LR, Raine AE. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO). Clin Nephrol 1993; 39:103-110.
39. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation 1993; 88:180-185.
40. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90:878-883.
41. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998; 98:1510-1516.
42. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Circulation 2000; 102:1239-1244.
43. Hathaway DK, Cashion AK, Milstead EJ, Winsett RP, Cowan PA, Wicks MN, Gaber AO. Autonomic dysregulation in patients awaiting kidney transplantation. Am J Kidney Dis 1998; 32:221-229.
44. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 1999; 14:1480-1488.
45. Vita G, Savica V, Milone S, Trusso A, Bellinghieri G, Messina C. Uremic autonomic neuropathy: recovery following bicarbonate hemodialysis. Clin Nephrol 1996; 45:56-60.
46. Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol 1999; 10:2577-2584.
47. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, Otto CA, Swanson DP, Beierwaltes WH. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981; 22:22-31.
48. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620-1624.
49. Tobes MC, Jaques S, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985; 26:897-907.
50. Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE. Evaluation of metaiodebenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 1993; 34:1140-1146.
51. 131I] meta-iodobenzylguanidine: concise communication. J Nucl Med 1981; 22:358-364.
52. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, Shinohara S. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 1986; 27:84-89.
53. 123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol 1995; 22:1-12.
54. Rose CP, Cousineau D, Goresky CA, De Champlain J. Constitutive nonexocytotic norepinephrine release in sympathetic curves of in situ canine heart. Am J Physiol 1994; 266:H1386-1394.
55. Mangner TJ, Tobes MC, Wieland DW, Sisson JC, Shapiro B. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 1986; 27:37-44.
56. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78:1192-1199.
57. Dae MW, O’Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995; 30:270-280.
58. 123I-MIBG in long-distance runners. J Nucl Cardiol 1997; 4:396-402.
59. Mantysaari M, Kuikka J, Hartikainen J, Mustonen J, Mussalo H, Tahvanainen K, Lansimies E, Uusitupa M, Pyorala K. Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction. J Nucl Med 1995; 36:956-961.
60. Sakata K, Shirotani M, Yoshida H, Kurata C. Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing. J Am Coll Cardiol 1997; 30:370-376.
61. Hartikainen J, Mustonen J, Kuikka J, Vanninen E, Kettunen R. Cardiac sympathetic denervation in patients with coronary artery disease without previous myocardial infarction. Am J Cardiol 1997; 80:273-277.
62. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989; 30:1182-1191.
63. Wakabayashi Y, Kurata C, Mikami T, Shouda S, Okayama K, Tawarahara K. Effects of cilazapril and verapamil on myocardial iodine-125-metaiodobenzylguani-dine accumulation in cardiomyopathic BIO 53.58 hamsters. J Nucl Med 1997; 38:1540-1545.
64. Lotze U, Kober A, Kaepplinger S, Neubauer S, Gottschild D, Figulla HR. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83:1548-1551.
65. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, Loi-sance D, Castaigne A, Syrota A. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917-923.
66. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33:471-477.
67. Somsen GA, Szabo BM, van Veldhuisen DJ, de Milliano PA, de Groot CA, Lie KI. Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure. Am Heart J 1997; 134:456-458.
68. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, Tsuchihashi K, Shimamoto K. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998; 5:579-590.
69. Kurata C, Shouda S, Mikami T, Uehara A, Ishikawa K, Tawarahara K, Nakano T, Matoh F, Takeuchi K. Metaiodobenzylguanidine and heart rate variability in heart failure. Jpn Circ J 1998; 62:770-772.
70. Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, Gourgon R, Merlet P. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999; 33:759-766.
71. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, Zipes DP. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993; 22:1344-1353.
72. 123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a “clinically normal” heart. Br Heart J 1993; 69:6-13.
73. Dae MW, Lee RJ, Ursell PC, Chin MC, Stillson CA, Moise NS. Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation 1997; 96:1337-1342.
74. 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 1999; 40:1-5.
75. Fujiwara Y, Hamada M, Shigematsu Y, Sumimoto T, Hamamoto K, Hiwada K. Scintigraphic assessment of cardiac adrenergic innervation in patients with essential hypertension. J Cardiovasc Pharmacol 1991; 17(suppl 2):S148-150.
76. Kuwahara T, Hamada M, Hiwada K. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998; 39:1486-1491.
77. 123I-MIBG. J Nucl Med 1999; 40:6-11.
78. Claus D, Feistel H, Brunholzl C, Platsch G, Neundorfer B, Wolf F. Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodobenzylguanidine measured by single photon emission computed tomography. Clin Auton Res 1994; 4:117-123.
79. 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Jpn Circ J 1995; 59:599-607.
80. Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995; 25:610-618.
81. 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Diabet Med 1996; 13:266-272.
82. Kurata C, Okayama K, Wakabayashi Y, Shouda S, Mikami T, Tawarahara K, Sugiyama T. Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats. J Nucl Med 1997; 38:1677-1680.
83. Uehara A, Kurata C, Sugi T, Mikami T, Shouda S. Diabetic cardiac autonomic dysfunction: parasympathetic versus sympathetic. Ann Nucl Med 1999; 13:95-100.
84. Sugiyama T, Kurata C, Tawarahara K, Nakano T. Is abnormal iodine-123-MIBG kinetics associated with left ventricular dysfunction in patients with diabetes mellitus? J Nucl Cardiol 2000; 7:562-568.
85. De Marco T, Dae M, Yuen-Green MS, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995; 25:927-931.
86. Guertner C, Krause BJ, Klepzig H, Jr., Herrmann G, Lelbach S, Vockert EK, Hartmann A, Maul FD, Kranert TW, Mutschler E. Sympathetic re-innervation after heart transplantation: dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination. Eur J Nucl Med 1995; 22:443-452.
87. Toba M, Ishida Y, Fukuchi K, Shimotsu Y, Takamiya M, Komamura K, Nakatani T, Ohuchi H, Ono Y, Kamiya T. Sympathetic reinnervation demonstrated on serial iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation. J Nucl Med 1998; 39:1862-1864.
88. 123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 1994; 49:81-84.
89. 123I-MIBG uptake by the heart in Parkinson’s disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999; 40:371-375.
90. Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, Ne-undorfer B. Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000; 175:3-12.
91. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, Noda T, Nishigaki K, Fujiwara H. Cardiac sympathetic denervation from the early stage of Parkinson’s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41:71-77.
92. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90:234-240.
93. Hojgaard MV, Holstein-Rathlou NH, Agner E, Kanters JK. Dynamics of spectral components of heart rate variability during changes in autonomic balance. Am J Physiol 1998; 275:H213-219.
94. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol 1999; 276:H215-223.
95. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997; 95:1449-1454.
96. Skyschally A, Breuer HW, Heusch G. The analysis of heart rate variability does not provide a reliable measurement of cardiac sympathetic activity. Clin Sci (Colch) 1996; 91:102-104.
97. Notarius CF, Butler GC, Ando S, Pollard MJ, Senn BL, Floras JS. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci (Colch) 1999; 96:557-565.
98. Psychari SN, Theodorakis GN, Koutelou M, Livanis EG, Kremastinos DT. Cardiac denervation after radiofrequency ablation of supraventricular tachycardias. Am J Cardiol 1998; 81:725-731.
99. 123I]metaiodobenzylguanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol 1997; 4:515-523.
100. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, Tsujimura E, Ito Y, Hori M, Kamada T, Nishimura T. Myocardial iodine-123-metaiodobenzyl-guanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997; 38:49-52.
101. Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, Merlet P, Le Guludec D. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999; 26:416-424.
102. 123I-MIBG-SPECT. Acta Neurol Scand 1999; 99:308-314.
103. Kurata C, Wakabayashi Y, Shouda S, Okayama K, Yamamoto T, Ishikawa A, Suzuki K, Ishizuka T, Sakamoto S, Tawarahara K. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Med 1995; 36:2037-2043.
104. 123I- mIBG in rats. Nucl Med Commun 1988; 9:663-667.
105. Dae MW, De Marco T, Botvinick EH, O’Connell JW, Hattner RS, Huberty JP, Yuen-Green MS. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts—implications for clinical studies. J Nucl Med 1992; 33:l444-l450.
106. 123I-MIBG kinetics in rats. J Nucl Med 1999; 40:2088-2093.
107. Rabinovitch MA, Rose CP, Schwab AJ, Fitchett DH, Honos GN, Stewart JA, Chen LF, Castilla EP, Gomez AA, Abrahamowicz M. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 1993; 34:589-600.
108. Eisenhofer G, Smolich JJ, Esler MD. Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. Am J Physiol 1992; 262:L360-365.
109. l3lI-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function. Eur J Nucl Med 1988; 13:543-547.
110. Ünlü M, Inanir S. Prolonged lung retention of iodine-123-MIBG in diabetic patients. J Nucl Med 1998; 39:116-118.
111. Murashima S, Takeda K, Matsumura K, Yamakado K, Sakuma H, Kitano T, Nakagawa T, Ichihara T, Yamakado T, Murata K. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med 1998; 39:334-338.
112. 123I-MIBG pulmonary removal: a biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 199G; 16:633-637.
113. Agarwal A, Anand IS, Sakhuja V, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int 1991; 40:489-495.
114. Bolton CF, Baltzan MA, Baltzan RB. Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study. N Engl J Med 1971; 284:1170-1175.
115. Strano S, De Castro S, Urani C, Ferrucci A, Marcheselli A, Poli L, Berloco P, Calcagnini G Jr, Cerutti S, Cortesini R. Power spectrum analysis of heart rate variability following kidney transplantation. Transplant Proc 1993; 25:2600-2601.
116. Yildiz A, Sever MS, Demirel S, Akkaya V, Türk S, Türkmen A, Ecder T, Ark E. Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron 1998; 80:57-60.
117. Cashion AK, Hathaway DK, Milstead EJ, Reed L, Gaber AO. Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant. Transplantation 1999; 68:1846-1850.
118. Kurata C, Uehara A, Sugi T, Yamazaki K. Improvement of uremic cardiac autonomic neuropathy by renal transplantation: metaiodobenzylguanidine and heart rate variability (abstr). Jpn Circ J 2000; 64:501.
119. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993; 88:136-145.
120. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93:1667-1676.
121. Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT. Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 1989; 111:635-640.
122. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60:908-914.
123. Christensen JH, Aaroe J, Knudsen N, Dideriksen K, Kornerup HJ, Dyerberg J, Schmidt EB. Heart rate variability and n-3 fatty acids in patients with chronic renal failure—a pilot study. Clin Nephrol 1998; 49:102-106.